Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Delâge

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Contraception|December 1, 1987
The classical and alternate pathways of complement in oral contraceptive usersJ M Delâge, G Lehner-Netsch, J Brisson
British Journal of Cancer|December 1, 1975
Increase in the gastrointestinal absorption and in tissue storage of cyclophosphamide in L-1210 leukaemic mice at an advanced stage of the diseaseJ G Lavigne, A Barry, C D'Auteuil, et al.
The Journal of Clinical Investigation|November 1, 1977
Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian familyJ M Delâge, P Bergeron, J Simard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1994
Familial hemolytic-uremic syndrome and homozygous factor H deficiencyV Pichette, S Quérin, W Schürch, et al.
British Journal of Haematology|June 1, 1997
Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosisR Delage, J Roy, L Jacques, et al.
Immunology|June 1, 1979
Simultaneous occurrence of hereditary C6 and C2 deficiency in a French-Canadian familyJ M Delâge, G Lehner-Netsch, R Lafleur, et al.
Clinical and Experimental Immunology|January 1, 1982
C3b inactivator deficiency with immune complex manifestationsP Solal-Celigny, M Laviolette, J Hebert, et al.
Cancer|August 1, 1986
Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 casesA De Gramont, C Louvet, M Krulik, et al.
Cancer|January 15, 1987
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's diseaseA de Gramont, C Louvet, M Krulik, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Contraception|December 1, 1987
The classical and alternate pathways of complement in oral contraceptive usersJ M Delâge, G Lehner-Netsch, J Brisson
British Journal of Cancer|December 1, 1975
Increase in the gastrointestinal absorption and in tissue storage of cyclophosphamide in L-1210 leukaemic mice at an advanced stage of the diseaseJ G Lavigne, A Barry, C D'Auteuil, et al.
The Journal of Clinical Investigation|November 1, 1977
Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian familyJ M Delâge, P Bergeron, J Simard, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1994
Familial hemolytic-uremic syndrome and homozygous factor H deficiencyV Pichette, S Quérin, W Schürch, et al.
British Journal of Haematology|June 1, 1997
Multiple bcl-2/Ig gene rearrangements in persistent polyclonal B-cell lymphocytosisR Delage, J Roy, L Jacques, et al.
Immunology|June 1, 1979
Simultaneous occurrence of hereditary C6 and C2 deficiency in a French-Canadian familyJ M Delâge, G Lehner-Netsch, R Lafleur, et al.
Clinical and Experimental Immunology|January 1, 1982
C3b inactivator deficiency with immune complex manifestationsP Solal-Celigny, M Laviolette, J Hebert, et al.
Cancer|August 1, 1986
Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 casesA De Gramont, C Louvet, M Krulik, et al.
Cancer|January 15, 1987
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's diseaseA de Gramont, C Louvet, M Krulik, et al.
Pageof 1